Specialty Hub Services/Patient Assistance Providers News Roundup
WAINUA™ for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis is available at Orsini Specialty Pharmacy
AMI’s annual Specialty Hub Service Providers Report provides comprehensive business intelligence on more than 70 companies
AMI’s annual Specialty Hub Service Providers Report provides comprehensive business intelligence on more than 70 companies
AMI’s annual Specialty Hub Service Providers Report provides comprehensive business intelligence on more than 70 companies
AMI’s Specialty Pharmacy Database continually monitors and tracks all limited and exclusive pharmacy distribution agreements
Xspray Pharma signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company’s first innovative cancer therapy Dasynoc
Envision Pharma Group acquires OKRA.ai, an award-winning technology company active in the provision of artificial intelligence (AI) solutions